相似文献
1
The Camerino symposium series (1978-2013): a privileged observatory of receptorology development.
In Silico Pharmacol. 2013 Dec 20;1:21. doi: 10.1186/2193-9616-1-21. eCollection 2013.
2
G protein-coupled receptors: computer-aided ligand discovery and computational structural analyses in the 2010s.
In Silico Pharmacol. 2013 Dec 20;1:20. doi: 10.1186/2193-9616-1-20. eCollection 2013.
3
Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):381-416. doi: 10.1007/s00210-002-0588-0. Epub 2002 Sep 6.
4
Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
Mol Cell Endocrinol. 2019 Mar 15;484:15-24. doi: 10.1016/j.mce.2019.01.021. Epub 2019 Jan 26.
5
Constitutive activity and inverse agonism at the α(₁a) and α(₁b) adrenergic receptor subtypes.
Methods Enzymol. 2010;485:123-38. doi: 10.1016/B978-0-12-381296-4.00007-5.
6
Conference report: trekking through receptor chemistry.
Future Med Chem. 2010 Aug;2(8):1247-52. doi: 10.4155/fmc.10.222.
7
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
Trends Pharmacol Sci. 2006 Feb;27(2):92-6. doi: 10.1016/j.tips.2005.12.007. Epub 2006 Jan 6.
8
GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
Trends Pharmacol Sci. 2014 May;35(5):247-55. doi: 10.1016/j.tips.2014.03.003. Epub 2014 Mar 30.
9
Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor.
J Pharmacol Exp Ther. 2006 Jan;316(1):279-88. doi: 10.1124/jpet.105.094383. Epub 2005 Sep 27.
10
Recognition of privileged structures by G-protein coupled receptors.
J Med Chem. 2004 Feb 12;47(4):888-99. doi: 10.1021/jm0309452.
引用本文的文献
1
G protein-coupled receptors: computer-aided ligand discovery and computational structural analyses in the 2010s.
In Silico Pharmacol. 2013 Dec 20;1:20. doi: 10.1186/2193-9616-1-20. eCollection 2013.
本文引用的文献
1
Structure and dynamics of the M3 muscarinic acetylcholine receptor.
Nature. 2012 Feb 22;482(7386):552-6. doi: 10.1038/nature10867.
2
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.
Nature. 2012 Jan 25;482(7386):547-51. doi: 10.1038/nature10753.
3
Progress in structure based drug design for G protein-coupled receptors.
J Med Chem. 2011 Jul 14;54(13):4283-311. doi: 10.1021/jm200371q. Epub 2011 Jun 15.
4
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Neuropharmacology. 2011 Jan;60(1):24-35. doi: 10.1016/j.neuropharm.2010.07.010. Epub 2010 Jul 15.
5
G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
ACS Chem Biol. 2008 Sep 19;3(9):530-41. doi: 10.1021/cb800116f. Epub 2008 Jul 25.
6
Allosteric modulation of heterodimeric G-protein-coupled receptors.
Trends Pharmacol Sci. 2007 Dec;28(12):615-20. doi: 10.1016/j.tips.2007.11.001. Epub 2007 Nov 19.
7
Allosteric modulation of G protein-coupled receptors.
Annu Rev Pharmacol Toxicol. 2007;47:1-51. doi: 10.1146/annurev.pharmtox.47.120505.105159.
8
Historical review: a brief history and personal retrospective of seven-transmembrane receptors.
Trends Pharmacol Sci. 2004 Aug;25(8):413-22. doi: 10.1016/j.tips.2004.06.006.
9
Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.
Mol Pharmacol. 2003 Jan;63(1):9-18. doi: 10.1124/mol.63.1.9.
10
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery.
Nat Rev Drug Discov. 2002 Mar;1(3):198-210. doi: 10.1038/nrd746.
Zotero 插件